Cancer Gene Therapy

Papers
(The H4-Index of Cancer Gene Therapy is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Reducing the risks of nuclear war—the role of health professionals116
Homeostatic cytokines tune naivety and stemness of cord blood-derived transgenic T cells93
Correction to: Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis73
Correction: UNC5B mediates G2/M phase arrest of bladder cancer cells by binding to CDC14A and P5370
Circ-GSK3B up-regulates GSK3B to suppress the progression of lung adenocarcinoma66
ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy62
Adeno-associated virus-delivered alpha synuclein inhibits bladder cancer growth via the p53/p21 signaling pathway53
Lysine-40 succinylation of TAGLN2 induces glioma angiogenesis and tumor growth through regulating TMSB4X51
Small extracellular vesicle TGF-β in cancer progression and immune evasion49
P38 kinase in gastrointestinal cancers46
Targeting TLK2 inhibits the progression of gastric cancer by reprogramming amino acid metabolism through the mTOR/ASNS axis45
Use of CRISPR-based screens to identify mechanisms of chemotherapy resistance45
Long noncoding RNA EPCART regulates translation through PI3K/AKT/mTOR pathway and PDCD4 in prostate cancer43
TNFRSF19 promotes endoplasmic reticulum stress-induced paraptosis via the activation of the MAPK pathway in triple-negative breast cancer cells43
CircPKN2 promotes ferroptosis in bladder cancer by promoting the ubiquitination of Stearoyl-CoA Desaturase 140
Correction to: FOXO3-induced lncRNA LOC554202 contributes to hepatocellular carcinoma progression via the miR-485-5p/BSG axis34
Role of non-coding RNAs in neuroblastoma33
Expressed prognostic biomarkers for primary prostate cancer independent of multifocality and transcriptome heterogeneity32
PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma32
Silencing of RND3/RHOE inhibits the growth of human hepatocellular carcinoma and is associated with reversible senescence31
Self-replicating messenger RNA based cancer immunotherapy30
SHMT2 promotes cell viability and inhibits ROS-dependent, mitochondrial-mediated apoptosis via the intrinsic signaling pathway in bladder cancer cells30
Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy30
The target atlas for antibody-drug conjugates across solid cancers27
Targeted inactivation of EWSR1 : : FLI1 gene in Ewing sarcoma via CRISPR/Cas9 driven by an Ewing-specific GGAA promoter26
Oncolytic adenoviruses synergistically enhance anti-PD-L1 and anti-CTLA-4 immunotherapy by modulating the tumour microenvironment in a 4T1 orthotopic mouse model26
Pathophysiological role of ion channels and transporters in HER2-positive breast cancer26
Combination of ZEN-3694 with CDK4/6 inhibitors reverses acquired resistance to CDK4/6 inhibitors in ER-positive breast cancer26
1.5015878677368